p53, PCNA, and Ki-67 in hydropic molar and nonmolar placentas: An immunohistochemical study

International Journal of Gynecological Pathology

Volumn 15, Issue 2, 1996, Pages 158-166

  Schammel, David P ^a   Bocklage, Thérèse ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Hydatidiform mole; Immunohistochemistry; Ki 67; p53; Placenta

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY KI 67; PROTEIN P53;

ARTICLE; CELL CYCLE S PHASE; CLINICAL ARTICLE; CYTOTROPHOBLAST; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PLACENTA; PLOIDY; PRIORITY JOURNAL; SYNCYTIOTROPHOBLAST;

EID: 0029990986     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199604000-00011     Document Type: Article

References (27)

1. Fox. H. Current topic: trophoblastic pathology. Placenta 1991;12:479-86.
2. Fukunaga M, Ushigome S, Fukunaga M, et al. Applications of flow cytometry in diagnosis of hydatidiform mole. Mod Pathol 1993;6:353-9.
3. Conran RM, Hitchcock CL, Griffin JL, et al. Hydatidiform moles: a clinicopathologic study. Am J Clin Pathol 1991;96: 408-11.
4. Howat AJ, Beck S, Fox H, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993;46:599-602.
5. Koenig C, Demopoulos RI, Vamvakas EC, et al. Flow cytometric DNA ploidy and quantitative histopathology in partial moles. Int J Gynecol Pathol 1993;12:235-40.
6. Takahashi H, Kanazawa K, Ikarashi T, et al. Discrepancy in the diagnoses of hydatidiform mole by macroscopic and microscopic findings and the deoxyribonucleic acid fingerprint method. Am J Obstet Gynecol 1990;163:112-13.
7. Szulman AE, Surti U. The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-71.
8. Szulman AE, Philippe E, Boue JG, et al. Human triploidy: association with partial hydatidiform moles and non-molar conceptuses. Hum Pathol 1981;12:1016-21.
9. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. In: Rosai J, Sobin LH, eds. Atlas of tumor pathology. Washington D.C.: Armed Forces Institute of Pathology, 1992:233-50.
10. Conran RM, Hitchcock CL, Popek EJ, et al. Diagnostic considerations in molar gestations. Hum Pathol 1993;24:41-8.
11. Hitchcock CL, Conran RM, Griffin JL. Hydatidiform moles and the use of flow cytometry in their diagnosis. Perspect Pediatr Pathol 1991;15:117-41.
12. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-7.
13. Lage JM, Popek EJ. The role of DNA flow cytometry in evaluation of partial and complete hydatidiform moles and hydropic abortions. Semin Diagn Pathol 1993;10:267-74.
14. Lage JM, Mark SD, Roberts DJ, et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 1992;79:403-10.
15. Lage JM, Berkowitz RS, Rice LW, et al. Flow cytometric analysis of DNA content in partial hydatidiform moles with persistent gestational trophoblastic tumor. Obstet Gynecol 1991;77:111-5.
16. Messerli ML, Parmley T, Woodruff JD, et al. Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet Gynecol 1987;69:622-6.
17. Suresh UR, Hale RJ, Fox H, et al. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles. J Clin Palhol 1993;46:48-50.
18. Gardner HAR, Lage JM. Choriocarcinoma following a partial hydatidiform mole: a case report. Hum Pathol 1992;23:468-70.
19. Wolf HK, Michalopoulos GK. Proliferating cell nuclear antigen in human placenta and trophoblastic disease. Pediatr Pathol 1992;12:147-54.
20. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular characterization of the cell proliferation- associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
21. Sutonen S, Kallioniemi OP, Isola JJ. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 1993;142:1081-9.
22. Cheung ANY, Ngan HYS, Chen WZ, et al. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study. Histopathology 1993;22:565-8.
23. Casasco A, Giordano M, Danova M, et al. PC10 monoclonal antibody to proliferating cell nuclear antigen as a probe for cycling cell detection in developing tissues. Histochemistry 1993;99:191-9.
24. Benjamin DR. Proliferating cell nuclear antigen (PCNA) and pediatric tumors: assessment of proliferative activity. Pediatr Pathol 1991;11:507-19.
25. Battifora A. p53 immunohistochemistry: a word of caution. Hum Pathol 1994;25:435-7.
26. Arias-Stella J Jr, Arias-Velasquez A, Arias-Stella J. Normal and abnormal mitoses in the atypical endometrial change associated with chronic tissue effect. Am J Surg Pathol 1994;18:694-701.
27. Marzusch K, Ruck P, Horny H-P, Dietl J, Kaiserling E. Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study [Short Communication]. Placenta 1995;16:101-4.